ArticleJournal of bioenergetics and biomembranes2021

KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/β-catenin signaling.

Ruimin Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.